Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - DarioHealth Corp.v461071_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - DarioHealth Corp.v461071_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - DarioHealth Corp.v461071_ex31-1.htm
10-K - 10-K - DarioHealth Corp.v461071_10k.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

 

We consent to the incorporation by reference in the Registration Statements on Form S-8 (File No. 333-211417 and 333-215829) and the Registration Statements on Form S-3 (File No. 333-211396, 333-212644, 333-214849 and 333-216607), of DarioHealth Corp. (“the Company”), of our report dated March 22, 2017 with respect to the consolidated financial statements of the Company and its subsidiaries included in this Annual Report on Form 10-K for the year ended December 31, 2016.

 

 

 

Tel-Aviv, Israel/s/   Kost Forer Gabbay & Kasierer
March 22, 2017  A Member of Ernst & Young Global